Jane Street Group, LLC Karyopharm Therapeutics Inc. Put Options Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 17, 2022	BUY	$5.91 - $14.38 $440,886 - $1.07 Million	74,600 Added 367.49%	94,900 $699,000
Q4 2021 Feb 15, 2022	SELL	$5.21 - $8.61 $10,941 - $18,081	-2,100 Reduced 9.38%	20,300 $131,000
Q3 2021 Nov 16, 2021	BUY	$4.45 - $10.63 $4,450 - $10,630	1,000 Added 4.67%	22,400 $130,000
Q2 2021 Aug 16, 2021	SELL	$8.11 - $11.11 $182,475 - $249,975	-22,500 Reduced 51.25%	21,400 $221,000
Q1 2021 May 18, 2021	SELL	$9.85 - $17.69 $94,560 - $169,824	-9,600 Reduced 17.94%	43,900 $462,000
Q4 2020 Feb 17, 2021	BUY	$14.15 - $17.19 $271,680 - $330,048	19,200 Added 55.98%	53,500 $828,000
Q3 2020 Nov 17, 2020	SELL	$14.14 - $19.71 $219,170 - $305,505	-15,500 Reduced 31.12%	34,300 $501,000
Q2 2020 Aug 17, 2020	BUY	$16.6 - $25.25 $826,680 - $1.26 Million	49,800 New	49,800 $943,000

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $67M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.